Man Li

467 Zhongshan Road
Dalian, 116023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 124 publications

Correction: RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.

Correction: RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.

Journal: Signal transduction and targeted therapy

Published: August 31, 2026

Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer.

Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: January 17, 2026

Polyunsaturated fatty acid-functionalized fucoidan nanoparticles targeting and regulating "tumor ecosystem" for metastatic cancer therapy.

Polyunsaturated fatty acid-functionalized fucoidan nanoparticles targeting and regulating "tumor ecosystem" for metastatic cancer therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 14, 2026

Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study.

Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: December 13, 2025

Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study.

Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study.

Journal: Breast (Edinburgh, Scotland)

Published: November 28, 2025

Dual-responsive diazo probe for labeling of aggrephagic compartments in live cells.

Dual-responsive diazo probe for labeling of aggrephagic compartments in live cells.

Journal: Talanta

Published: August 31, 2025

Molecular Mechanisms and Therapeutic Strategies for Immune Checkpoint Inhibitors in Breast Cancer: From Pathogenesis to Precision Medicine.

Molecular Mechanisms and Therapeutic Strategies for Immune Checkpoint Inhibitors in Breast Cancer: From Pathogenesis to Precision Medicine.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 23, 2025

The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data.

The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data.

Journal: Frontiers in immunology

Published: August 11, 2025

Exosomal Liquid Biopsy for the Early Detection of Gastric Cancer: The DESTINEX Multicenter Study.

Exosomal Liquid Biopsy for the Early Detection of Gastric Cancer: The DESTINEX Multicenter Study.

Journal: JAMA surgery

Published: July 30, 2025

Intra-tumoral microbial heterogeneity of breast cancer: roles in tumorigenesis, therapeutic responses, and future directions.

Intra-tumoral microbial heterogeneity of breast cancer: roles in tumorigenesis, therapeutic responses, and future directions.

Journal: Journal of applied microbiology

Published: July 11, 2025

Precise targeting cytotoxicity of antibody-drug conjugate combined with immunotherapy as first-line regimen for metastatic triple-negative breast cancer in ASCENT-04.

Precise targeting cytotoxicity of antibody-drug conjugate combined with immunotherapy as first-line regimen for metastatic triple-negative breast cancer in ASCENT-04.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: June 21, 2025

Decoy Extracellular Vesicles Overcome Triple-Negative Breast Cancer Heterogeneity via Membrane-Cytoplasm-Mitochondria Cascade Targeting.

Decoy Extracellular Vesicles Overcome Triple-Negative Breast Cancer Heterogeneity via Membrane-Cytoplasm-Mitochondria Cascade Targeting.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 10, 2025

Showing 1-12 of 124

Last Updated: 09/26/2026